Exploring the Potential of Atmospheric Plasma in Advanced Wound Healing Technologies

Ahmet Yılmaz^*
*Correspondence: Ahmet Yılmaz, Department of Tissue Engineering and Regenerative, Aydin Adnan Menderes University, Aydin 09100, Turkey, Email:

Introduction

Wound healing is a complex and multi-stage process that is essential for restoring tissue integrity after injury. However, the treatment of chronic wounds, such as diabetic foot ulcers, venous ulcers and pressure sores, remains a significant challenge in modern healthcare. These wounds often fail to heal due to persistent inflammation, infection, or poor tissue regeneration, leading to prolonged recovery times and a substantial healthcare burden. Traditional wound care methods, while essential, are often inadequate for promoting rapid healing in such cases. In recent years, the advent of advanced technologies has provided promising solutions to this issue [1].

One such innovation is Atmospheric Plasma Therapy (APT), a non-thermal plasma-based treatment that has shown remarkable potential in enhancing wound healing. Atmospheric plasma is a partially ionized gas generated at room temperature, containing charged particles and reactive species such as Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS), which are believed to facilitate wound healing by promoting antimicrobial activity, reducing inflammation and stimulating tissue regeneration. This article explores the potential of atmospheric plasma in advanced wound healing technologies, focusing on its mechanisms of action, clinical applications and future directions for research [2].

Description

Atmospheric plasma operates at atmospheric pressure and room temperature, making it an ideal candidate for biomedical applications, including wound care. The key components of atmospheric plasma such as ions, electrons, ROS and RNS have been found to interact with biological tissues in a way that promotes wound healing. The antimicrobial effects of plasma, particularly its ability to kill bacteria and fungi, make it especially beneficial for treating chronic wounds, which are often complicated by infections. By generating ROS and RNS, atmospheric plasma can directly disrupt the cell membranes of pathogens, thereby reducing infection rates and improving the likelihood of wound closure. Beyond its antimicrobial effects, plasma also influences cellular processes critical for tissue regeneration. Research has shown that exposure to atmospheric plasma stimulates cell proliferation, migration and collagen synthesis, all of which are vital for effective wound healing [3].

 Additionally, plasma therapy has been shown to induce angiogenesis, the process by which new blood vessels form, thus enhancing blood supply to the damaged tissue and facilitating faster recovery. Atmospheric plasma has been particularly effective in the treatment of chronic wounds such as diabetic foot ulcers and venous leg ulcers, where traditional treatments often fail. Clinical trials have demonstrated that plasma therapy can significantly accelerate wound closure, reduce the time to complete healing and lower the incidence of infection. The therapyâ??s non-invasive nature, coupled with its ability to promote faster healing, makes it an attractive alternative to more conventional methods. However, despite the promising results, several challenges remain [4].

These include a lack of standardized treatment protocols, variations in plasma device technologies and the need for further regulatory approval. Additionally, while the mechanism of action is increasingly understood, there is still a need for more in-depth studies on the long-term safety and efficacy of plasma therapy in wound care. Another area of significant interest is the combination of atmospheric plasma with other advanced wound healing technologies, such as stem cell therapy and growth factor treatments. This could potentially offer a synergistic effect, where plasma enhances the regenerative capacity of other therapies, leading to more comprehensive wound healing solutions. While there is a growing body of evidence supporting the benefits of atmospheric plasma, more large-scale clinical trials are necessary to establish clear guidelines for its use and to fully integrate it into clinical practice [5].

Conclusion

In conclusion, atmospheric plasma therapy holds considerable promise as an advanced technology for wound healing. Its unique properties, including antimicrobial activity, stimulation of tissue regeneration and ability to accelerate wound closure, make it a powerful tool in the treatment of both chronic and acute wounds. While significant progress has been made in understanding the mechanisms by which plasma promotes healing, there remain challenges in standardizing treatment protocols and gaining broader regulatory acceptance. Nonetheless, the potential of atmospheric plasma to revolutionize wound care is undeniable. Continued research into its mechanisms of action, clinical efficacy and integration with other wound healing therapies will likely lead to more widespread adoption in clinical practice. As plasma-based technologies evolve, healthcare providers and patients alike can look forward to improved treatment outcomes, faster recovery times and enhanced quality of life for those suffering from difficult-to-heal wounds. Ultimately, atmospheric plasma could play a pivotal role in shaping the future of wound care, making it an essential component of modern medical practice.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Arndt, Stephanie, Petra Unger, Eva Wacker and Tetsuji Shimizu, et al. "Cold Atmospheric Plasma (CAP) changes gene expression of key molecules of the wound healing machinery and improves wound healing in vitro and in vivo." PloS one 8 (2013): e79325.

Google Scholar Cross Ref Indexed at

2. Stratmann, Bernd, Tania-Cristina Costea, Catharina Nolte and Jonas Hiller, et al. "Effect of cold atmospheric plasma therapy standard therapy placebo on wound healing in patients with diabetic foot ulcers: A randomized clinical trial." JAMA Netw Open 3 (2020): e2010411-e2010411.

Google Scholar Cross Ref Indexed at

3. Haertel, Beate, Thomas Von Woedtke, Klaus-Dieter Weltmann and Ulrike Lindequist. "Non-thermal atmospheric-pressure plasma possible application in wound healing." Biomol Ther 22 (2014): 477.

Google Scholar Cross Ref Indexed at

4. Weltmann, Klaus Dieter, Eckhard Kindel, Thomas von Woedtke and Marcel Hähnel, et al. "Atmospheric-pressure plasma sources: Prospective tools for plasma medicine." Pure Appl Chem 82 (2010): 1223-1237.

Google Scholar Indexed at

5. Wende, Kristian, Thomas von Woedtke, Klaus-Dieter Weltmann and Sander Bekeschus. "Chemistry and biochemistry of cold physical plasma derived reactive species in liquids." Biol Chem 400 (2018): 19-38.

Google Scholar Cross Ref Indexed at